Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on August 27, 2025

Lionbridge Selected for Training Industry’s 2025 Top 20 AI Content Creation and Authoring Tools Companies
Lionbridge Content Remix App™ recognized as a leading tool for streamlining and enhancing the design, development, and delivery of multilingual learning content WALTHAM, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- Lionbridge, a global …

Boston Estate Planning Council Receives Prestigious 2025 NAEPC Council of Excellence Award
This award is the highest recognition given to affiliated councils. WESTFORD, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- The Boston Estate Planning Council (BEPC), Greater Boston’s leading professional organization for estate and wealth …

Powered by Community, MassQ Ball 2025 Brings Joy and Art to Boston This Fall
MassQ Ball 2025: Color unites communities through music, dance, ritual, and art in the Arnold Arboretum’s Conifer Collection this October. BOSTON, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- Co-producers Castle of our Skins, …

BioVentrix Names Vinod H. Thourani, MD and Marat Fudim, MD, MHS as National Co-Principal Investigators for RELIVE Trial
Renowned Cardiologists to Lead Pivotal Trial Evaluating the BioVentrix Revivent System for Heart Failure Patients MANSFIELD, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- BioVentrix, Inc., a medical device company focused on developing …

High-Throughput Proteomics Analysis at MtoZ Biolabs
Proteomics analysis provides an advanced solution for the comprehensive identification, quantification, and functional characterization of proteins. BOSTON, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- Proteomics analysis is a solution for …

MtoZ Biolabs' Mass Spectrometry-Based Protein Identification Solutions
MS-based protein identification enables comprehensive identification of thousands of proteins. BOSTON, MA, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- Protein Identification refers to the experimental confirmation of a protein's identity, …

IPG Photonics to Debut New Field-Ready Laser Defense System for Counter-UAS Applications at DSEI UK 2025 in London
MARLBOROUGH, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- IPG Photonics, the global leader in fiber laser technology, proudly announces the first public display of the CROSSBOW™ MINI 3 kW high-energy laser (HEL) system at Defence and Security Equipment …

Editas Medicine to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the …

Mimecast Appoints Leslie Nielsen as Chief Information Security Officer
LEXINGTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Mimecast, a global cybersecurity leader redefining how organizations secure human risk through precision-engineered AI, today announced that Leslie Nielsen has joined the company as Chief Information …

Rapid7 Named a Leader in 2025 IDC MarketScape for Exposure Management
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced it has been positioned in the Leaders category of the IDC MarketScape: Worldwide Exposure Management 2025 Vendor …

Advent Technologies engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets
LIVERMORE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pleased to announce that it has engaged Fata Advisory, LLC to support the Company …

Alpha Tau to Participate in Five September Investor Conferences
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present and meet …

Disc Medicine to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Kailera Therapeutics to Participate in Upcoming Investor Conferences
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …

Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
SCHAFFHAUSEN, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, and Intel, today announced Acronis Cyber Protect Cloud’s availability with AI PCs powered by Intel Core Ultra processors, a new …

Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for IgA Nephropathy
Results reinforce telitacicept’s potential across multiple autoimmune diseases Data anticipated to be presented at an upcoming medical conference CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology …

Flare Therapeutics to Participate in Upcoming Investor Conferences in September
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …

Dyne Therapeutics to Present at Upcoming Investor Conferences
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management …

Minovia Therapeutics מודיעה על מענק של 350,000 דולר מקרןCountdown for a Cure לפיתוח סמנים ביולוגיים מבוססי דם של מיטוכונדריה
חיפה, ישראל, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd("מינוביה" או "החברה"), חברת ביוטכנולוגיה בשלבים קליניים המפתחת טיפולים חדשניים לטיפול במחלות מיטוכונדריאליות ולמאבק בהידרדרות הקשורה לגיל, מודיעה כי נבחרה לקבל מענק של 350,000 דולר מ- …

Invivyd to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside …